HALO logo
halo search icon
abrdn Life Sciences Investors of Benef Interest
abrdn Life Sciences Investors of Benef Interest
HQL · NYS

abrdn Life Sciences Investors of Benef Interest

US$17.66

Price Arrow0.25 (1.44%)
20/05/2026 04:10:00 PM
All-MF
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

abrdn Life Sciences Investors of Benef Interest Overview

HQL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About HQL

icon

Telephone

1.617.772.8500

icon

Address

Suite 200, 1900 Market Street, Philadelphia, PA 19103

Description

abrdn Healthcare Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.

HQL Price Chart

Key Stats

Market Cap

US$529.40M

PE

5.40

EV/EBITDA

5.3

Dividends Overview

DIV Yield

11.7%

Franking

N/A

Ex Dividend Date (est.)

21-May-26

Market Data

52 weeks range

Low 12.12 - 18.46

Trade Value (12mth)

US$528,201.00

1 week

-2.08%

1 month

-2.74%

YTD

3.82%

1 year

38.73%

All time high

31.21

Key Fundamentals

EPS 3 yr Growth

-171.00%

EBITDA Margin

286.90%

Operating Cashflow

-$2m

Free Cash Flow Return

-0.50%

ROIC

17.60%

Interest Coverage

0.00

Quick Ratio

7.50

Other Data

Shares Outstanding (Fully Diluted)

29m

HALO Sector

Other Finance

Next Company Report Date

N/A

Next Ex Dividend Date

21-May-26

Next Dividend Pay Date

30-Jun-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

HQL Announcements

Latest Announcements

DateAnnouncements
09 December 25
10 June 25
10 December 24
11 June 24
12 December 23

HQL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.833.042.89locklocklock
EPS (Fully Diluted)
$locklocklocklock0.833.042.89locklocklock
Growth
%locklocklocklock120.5264.3-4.9locklocklock
PE
Xlocklocklocklock14.955.4locklocklock
EV/EBITDA
Xlocklocklocklock14.34.85.3locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

21-May-26

DIV Yield

11.7%

Franking Level

N/A

DPSg

-2.2%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of abrdn Life Sciences Investors of Benef Interest (HQL:NYS)?
Halo FAQ
The current share price of abrdn Life Sciences Investors of Benef Interest (HQL:NYS) is USD$17.66.
What is the 52-week high share price for abrdn Life Sciences Investors of Benef Interest (HQL:NYS)?
Halo FAQ
The 52-week high share price for abrdn Life Sciences Investors of Benef Interest (HQL:NYS) is USD$18.46.
What is the 52-week low share price for abrdn Life Sciences Investors of Benef Interest (HQL:NYS)?
Halo FAQ
The 52-week low share price for abrdn Life Sciences Investors of Benef Interest (HQL:NYS) is USD$12.12.
What is the dividend yield for abrdn Life Sciences Investors of Benef Interest (HQL:NYS)?
Halo FAQ
The current TTM dividend payout for abrdn Life Sciences Investors of Benef Interest (HQL:NYS) is 11.70.
What was abrdn Life Sciences Investors of Benef Interest (HQL:NYS) last dividend payment?
Halo FAQ
The last dividend payment of abrdn Life Sciences Investors of Benef Interest (HQL:NYS) is USD$0.56.
What is the franking level for abrdn Life Sciences Investors of Benef Interest (HQL:NYS)?
Halo FAQ
abrdn Life Sciences Investors of Benef Interest (HQL:NYS) has a franking level of 0.00%.
In which sector is abrdn Life Sciences Investors of Benef Interest (HQL:NYS) classified?
Halo FAQ
abrdn Life Sciences Investors of Benef Interest (HQL:NYS) is classified in the Other Finance.
What is the price-to-earnings (P/E) ratio for abrdn Life Sciences Investors of Benef Interest (HQL:NYS)?
Halo FAQ
The current P/E ratio for abrdn Life Sciences Investors of Benef Interest (HQL:NYS) is 5.40.

See beyond the curve.

One solution for research, investing and portfolio management.